45 results on '"Orvieto, Raoul"'
Search Results
2. The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
3. Pretreatment: Does it improve quantity or quality?
4. Chapter 13 - Triggering final oocyte maturation. The role of human chorionic gonadotropin, gonadotropin-releasing hormone agonist, and dual trigger
5. Dibutyl phthalate impairs steroidogenesis and a subset of LH-dependent genes in cultured human mural granulosa cell in vitro
6. In Vitro Fertilization Outcomes After Placement of Essure Microinserts in Patients With Hydrosalpinges Who Previously Failed In Vitro Fertilization Treatment: A Multicenter Study
7. Reproductive Outcome Is Favorable After Laparoscopic Resection of Bladder Endometriosis
8. The use of preimplantation genetic testing for aneuploidy: a committee opinion
9. List of contributors
10. Insight: Prolonged Vaginal Bleeding during Central Precocious Puberty Therapy with a Long-acting Gonadotropin-Releasing Hormone Agonist: A Proposed Mechanism and Management Plan
11. Infertility counseling for Orthodox Jewish couples
12. EXPOSOME PROFILING REVEALS WIDESPREAD ENVIRONMENTAL POLLUTANT EXPOSURE IN SEMINAL PLASMA AND PREVIOUSLY UNKNOWN ASSOCIATIONS WITH MALE FERTILITY
13. Immediate ambulation after embryo transfer: A prospective study
14. Challenges encountered in predicting live birth after in vitro fertilization in the different phenotypes of patients with polycystic ovary syndrome
15. Effect of urinary versus recombinant follicle-stimulating hormone on platelet function and other hemostatic variables in controlled ovarian hyperstimulation
16. Echogenic bowel in intrauterine growth restriction fetuses: does this jeopardize the gut?
17. THE SEX OF PRIOR PREGNANCIES AFFECTS THE RISK OF PRIMARY OVARIAN INSUFFICIENCY
18. UTILIZATION OF GONADOTROPIN-RELEASING HORMONE AGONIST (GNRHA) TRIGGER IN GnRH ANTAGONIST CYCLES: DOES THE TIME INTERVAL FROM LAST ANTAGONIST ADMINISTRATION MATTER?
19. “ADD-ONS” IN ART: DO PATIENTS RECEIVE HONEST INFORMATION THROUGH FERTILITY CLINICS’ WEBSITES?
20. 1153: Mode of delivery and ovarian reserve – the effect of Cesarean versus vaginal delivery
21. 816: Unbiased appraisal of the association between physical activity following embryo transfer and pregnancy- Prospective study
22. 630: Impact of the mode of conception on pregnancy complications at very advanced maternal age
23. Hemoperitoneum After Oocyte Retrieval and Severe Pelvic Infection
24. The Ovulation: Double and Dual Triggering
25. Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome
26. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy
27. Follitropin-α (Gonal-F) versus follitropin-β (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
28. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists
29. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
30. Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality
31. GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori
32. Is there a limit for the number of in vitro fertilization cycles for an individual patient?
33. Do stimulation characteristics of the first in vitro fertilization cycle predict pregnancy in women of 40 years old and over?
34. Controlled ovarian hyperstimulation: are we monitoring the appropriate sex-steroid hormones?
35. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs
36. Gestrinone in the treatment of uterine leiomyomata: Effects on uterine blood supply
37. Müllerian-inhibiting substance in women with polycystic ovary syndrome: Relationship with hormonal and metabolic characteristics
38. Reply: Appropriate methods to monitor controlled ovarian hyperstimulation?
39. Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?
40. Does methotrexate treatment for ectopic pregnancy influence the patient's performance during a subsequent in vitro fertilization/embryo transfer cycle?
41. A simplified approach to religious infertility
42. Insulin autoantibodies in cord blood from neonates with and without a sibling with type 1 diabetes: prevalence and characteristics
43. Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient
44. A severe case of ovarian hyperstimulation syndrome despite the prophylactic administration of intravenous albumin
45. Etiology of ovarian hyperstimulation syndrome?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.